BioSpace News Archive

Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that it has been performing user testing with human subjects in Vancouver, BC with its version 2.0 THC Breath Analyzer (“THCBA”)

PostProcess Technologies Inc., the first and only global provider of automated and intelligent post-printing solutions for industrial 3D printing, has announced another patent granted in the United States. U.S. Patent No. 10,737,440, “

Vivera Pharmaceuticals, Inc. announced today the development of a new one-step testing cartridge for COVID-19 antibody testing. The ground-breaking cartridge will use a simplified procedure to help eliminate operator err

RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for detecting suspected LVOs (Large Vessel Occlusions). Rapid LVO helps physicians speed up triage or transfer decision-making. Working in as few as 3 minutes, Rapid LVO uses a vessel tracker in conjunction with assessment of brain regions with reduced blood vessel

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, announced today that the company will deliver a presentation at the MoneyShow Las Vegas Virtual Expo that is being held August 18 – 20, 2020. E

Medidata, a Dassault Systèmes company, announced the launch of Medidata Detect, a centralized statistical monitoring solution that improves data quality and promotes patient safety in clinical trials for new medicines, vaccines and medical devices. Medidata Detect , part of Medidata’s industry-leading, regulatory-compliant and unified Medidata Rave Clinical Cloud platform, helps customers manage data quality, monitor site pe

CB Insights today named digital therapeutics leader, Happify Health , to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. Happify Health has been recognized for their achievements in the ranking’s Disease Management and Therapeutics category. This press r

The push for pharmaceutical innovation has prompted drug sponsors to streamline their supply chains and dedicate those resources toward faster product development, which has propelled growth in the Pharmaceutical Services Outsourcing industry, according to the Healthcare & Life Sciences Insider

If approved, Xolair self-administration would offer a more flexible option to help select patients manage their treatment needs

Filing acceptance is based on the well-established efficacy and safety profile of Xolair in allergic asthma and chronic idiopathic urticaria